Proteins identified in study represent valuable cancer biomarkers detectable in plasma. »
01/05/23

Consistent downregulation of miR-1 observed in tumor tissues. »
01/04/23

Dose to skin in patients treated prospectively for HNC reduced by including gEUD. »
01/14/23

Overall mortality rates for pre- versus post-ruxolitinib approval cohorts 79.8% versus 47.3%, respectively. »
01/14/23

SL indicated after primary resection for cholecystitis. »
01/14/23

Combination of low-dose nitric oxide donor and cisplatin induced an additive cancer therapeutic effect in two immunocompetent animal models. »
01/14/23

FOXJ1 protein expression exhibited linear, increasing association with improved overall survival in HGSC patients. »
01/25/22

GRSs independently associated with lethal PCa risk after accounting for family history and race/ancestry. »
08/04/22

PERGC signature translated into liquid biopsy assay and is independent predictor for ER. »
08/12/22

Median overall survival for all patients was 38 months following complete cytoreduction. »
08/15/22